ReviewJournal of thoracic disease2018

Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: focusing on non-small cell lung cancer patients.

Jordi Remon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.